News Room

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Dealertrack Technologies Inc (NASDAQ: TRAK) acted responsibly on behalf of investors’ profitability in the planned $4 billion sale to Cox Automotive Inc. […]

06-15-2015

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of GlobeImmune Inc (NASDAQ: GBIM) violated securities laws in connection with certain financial statements. […]

06-14-2015

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) violated securities laws in connection with certain financial statements. […]

06-11-2015

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Deutsche Bank AG (NYSEMKT: DB) violated securities laws in connection with certain financial statements. […]

06-11-2015

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Bio-Reference Laboratories Inc (NASDAQ: BRLI) acted responsibly on behalf of investors’ profitability in the planned $1.47 billion sale to Opko Health Inc (NYSE: OPK). […]

06-05-2015

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Amedisys Inc (NASDAQ: AMED) violated securities laws in connection with certain financial statements. […]

06-05-2015

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of AMC Entertainment Holdings Inc (NYSEMKT: AMC) violated securities laws in connection with certain financial statements. […]

06-01-2015

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Rally Software Development Corp (NYSE: RALY) acted responsibly on behalf of investors’ profitability in the planned $480 million sale to CA, Inc (NASDAQ: CA) […]

05-29-2015

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of GrafTech International Ltd (NYSE: GTI) acted responsibly on behalf of investors’ profitability in the planned $150 million sale to an affiliate of Brookfield Asset Management (NYSE: BAM). […]

05-25-2015

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Frisch's Restaurants Inc (NYSE: FRS) acted responsibly on behalf of investors’ profitability in the planned $175 million sale to NRD Partners I, LP. […]

05-25-2015

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of EVINE Live Inc (NASDAQ: EVLV) violated securities laws in connection with certain financial statements. […]

05-20-2015

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Borderfree Inc (NASDAQ: BRDR) acted responsibly on behalf of investors’ profitability in the planned $400 Million sale to Pitney Bowes Inc (NYSE: PBI). […]

05-20-2015

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Perfect World Co Ltd (NASDAQ: PWRD) acted responsibly on behalf of investors’ profitability in the planned $900 Million sale to Perfect Peony Holding Company Limited […]

05-20-2015

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Quality Distribution Inc (NASDAQ: QLTY) acted responsibly on behalf of investors’ profitability in the planned $800 million sale to Apax Partners. […]

05-20-2015

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Synageva BioPharma Corp (NASDAQ: GEVA) acted responsibly on behalf of investors’ profitability in the planned $8.4 billion sale to Alexion Pharmaceuticals Inc (NASDAQ: ALXN). […]

05-20-2015